Skip to main content

Advertisement

Table 1 Characteristics of study participants at the screening test (n = 21)

From: Development of low-volume, high-intensity, aerobic-type interval training for elderly Japanese men: a feasibility study

Age, years 67.6 ± 1.8
Height, cm 167.1 ± 6.6
Weight, kg 68.1 ± 8.7
Systolic blood pressure, mmHg 134.8 ± 15.4
Diastolic blood pressure, mmHg 84.0 ± 8.9
Resting heart rate, beats/min 70.3 ± 7.5
Hypertension, n (%) 7 (33.3)
Diabetes, n (%) 4 (19.0)
Hyperlipidemia, n (%) 2 (9.5)
Arthralgia, n (%) 10 (47.6)
Arrhythmia, n (%) 6 (28.6)
V̇O2 peak, mL/kg/min 27.8 ± 4.2
Heart rate peak, beats/min 154.9 ± 14.9
Albumin, g/dL 4.3 ± 0.2
Total cholesterol, mg/dL 210.0 ± 26.3
High-density lipoprotein cholesterol, mg/dL 63.6 ± 14.5
Low-density lipoprotein cholesterol, mg/dL 124.7 ± 20.6
Triglyceride, mg/dL 105.3 ± 41.6
Free fatty acid, mEq/L 0.7 ± 0.2
Urea nitrogen, mg/dL 15.8 ± 2.6
Creatinine, mg/dL 0.9 ± 0.1
Serum iron, μg 111.5 ± 43.0
White blood cell, μL 6166.7 ± 2050.4
Red blood cell, 104μL 507.2 ± 48.3
Hemoglobinometry 15.5 ± 0.9
Hematocrit, % 47.8 ± 2.8
Fasting blood glucose, mg/dL 106.6 ± 18.3
Hb-A1c, % 6.1 ± 0.7
Immunoreactive insulin, μU/mL 6.4 ± 2.9
HOMA-R 1.7 ± 1.0
High-sensitivity C-reactive protein (>0.2 mg/dL), n (%) 2 (9.5)
NT-proBNP (>400 pg/mL), n (%) 0 (0)
  1. HOMA-R homeostatic model assessment of insulin resistance, NT-proBNP N-terminal pro-brain natriuretic peptide)